Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Toujeo (previously Optisulin)“
Suchtreffer
Begriffe & Kennungen
Toujeo (previously Optisulin)
Eintrag öffnenToujeo (previously Optisulin) · 4.1 Therapeutic indications · 1
Eintrag öffnenToujeo (previously Optisulin) · 4.3 Contraindications · 1
Eintrag öffnenToujeo (previously Optisulin) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenToujeo (previously Optisulin) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenToujeo (previously Optisulin) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenToujeo (previously Optisulin) · 4.5 · A number of substances affect glucose metabolism and may require dose adjustment of insulin glargine.
Eintrag öffnenToujeo (previously Optisulin) · 4.5 · Beta-blockers, clonidine, lithium salts or alcohol may either potentiate or weaken the blood-glucose-lowering
Eintrag öffnenToujeo (previously Optisulin) · 4.5 · Substances that may enhance the blood-glucose-lowering effect and increase susceptibility to hypoglycaemia inc
Eintrag öffnenToujeo (previously Optisulin) · 4.5 · Substances that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diur
Eintrag öffnenToujeo (previously Optisulin) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenToujeo (previously Optisulin) · 4.8 Undesirable effects · 1
Eintrag öffnenToujeo (previously Optisulin) · 4.8 · 8 Description of selected adverse reactions Metabolism and nutrition disorders Severe hypoglycaemic attacks, e
Eintrag öffnenToujeo (previously Optisulin) · 4.8 · Eyes disorders A marked change in glycaemic control may cause temporary visual impairment, due to temporary al
Eintrag öffnenToujeo (previously Optisulin) · 4.8 · General disorders and administration site conditions Injection site reactions include redness, pain, itching,
Eintrag öffnenToujeo (previously Optisulin) · 4.8 · Immune system disorders Immediate-type allergic reactions to insulin are rare. Such reactions to insulin (incl
Eintrag öffnenToujeo (previously Optisulin) · 4.8 · In many patients, the signs and symptoms of neuroglycopenia are preceded by signs of adrenergic counter-regula
Eintrag öffnenToujeo (previously Optisulin) · 4.8 · Long-term improved glycaemic control decreases the risk of progression of diabetic retinopathy. However, inten
Eintrag öffnenToujeo (previously Optisulin) · 4.8 · MedDRA Very common Common Uncommon Rare Very Not known system organ rare classes Immune system Allergic disord
Eintrag öffnenToujeo (previously Optisulin) · 4.8 · Other special populations Based on the results from clinical studies, the safety profile of Toujeo in elderly
Eintrag öffnen